Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1663632

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Palliative Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support patients receiving end-of-life care.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	201486
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>As set out in the Health and Care Act 2022, it is the legal duty of integrated care boards (ICBs) to commission palliative and end of life care to meet the needs of their local population. To support commissioners to fulfil this duty, NHS England has published statutory guidance and service specifications for both adults, and children and young people, which provide guidance to ICBs on enabling high-quality commissioning of services that meet both population need and preferences.</p><p>In addition, ICBs are supported by Palliative and End of Life Care Strategic Clinical Networks which work to progress and implement sustainable commissioning models for equitable, high-quality services.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 16:17:22 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1663630

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support people living with epilepsy.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	201484
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>The majority of health services for people with epilepsy are commissioned locally by integrated care boards (ICBs). ICBs are best placed to make decisions regarding the provision of health services to their local population, including for the treatment of epilepsy, subject to local prioritisation and funding.</p><p>At a national level, there are several initiatives supporting service improvement for those with epilepsy, including NHS England’s Neuroscience Service Transformation Programme and RightCare Epilepsy Toolkit.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 16:16:01 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1665019

	registered interest
	date	16/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Diseases: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase awareness of pulmonary fibrosis.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	202713
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>Patients with pulmonary fibrosis are cared for by National Health Service regional specialist Interstitial Lung Disease (ILD) services, who are commissioned by NHS England. To be referred to a specialist service patients need to be identified in primary and secondary care. Early and accurate diagnosis is a priority for NHS England, and the work to improve this area of clinical care is underway, which should have an impact on reducing delayed diagnosis of pulmonary fibrosis.</p><p>NHS England is responsible for the commissioning of services for ILD and funds the cost of anti-fibrotic treatments to treat this disease. Access to these treatments has recently been expanded to patients with non-idiopathic pulmonary fibrosis following the publication of the National Institute for Health and Care Excellence’s technology appraisal ‘Nintedanib for treating progressive fibrosing interstitial lung diseases’ in November 2021.</p><p>The Department has no plans for an awareness campaign.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 202714 question first answered 19/10/2023 15:57:32 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1665020

	registered interest
	date	16/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Diseases: Diagnosis and Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to (a) early diagnosis and (b) treatment for people living with pulmonary fibrosis.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	202714
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>Patients with pulmonary fibrosis are cared for by National Health Service regional specialist Interstitial Lung Disease (ILD) services, who are commissioned by NHS England. To be referred to a specialist service patients need to be identified in primary and secondary care. Early and accurate diagnosis is a priority for NHS England, and the work to improve this area of clinical care is underway, which should have an impact on reducing delayed diagnosis of pulmonary fibrosis.</p><p>NHS England is responsible for the commissioning of services for ILD and funds the cost of anti-fibrotic treatments to treat this disease. Access to these treatments has recently been expanded to patients with non-idiopathic pulmonary fibrosis following the publication of the National Institute for Health and Care Excellence’s technology appraisal ‘Nintedanib for treating progressive fibrosing interstitial lung diseases’ in November 2021.</p><p>The Department has no plans for an awareness campaign.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 202713 question first answered 19/10/2023 15:57:32 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1663633

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the Government is taking steps to reduce inequalities in access to medicinal cannabis prescribed under the NHS.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	201487
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.</p><p>Funding of unlicensed products is subject to local National Health Service decisions on a case-by-case basis. These decisions follow clearly developed procedures that ensure equitable distribution of funding, prioritising those medicines that have proved their safety, quality, and clinical and cost effectiveness.</p><p>We continue to call on manufacturers to conduct research to prove if their products are safe and effective and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 14:43:27 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1663631

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Patients
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help manage the (a) affordability and (b) value for money in the cost of medicines purchased by patients.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	201485
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>The Department has no role in the costs of medicines purchased in the private sector.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 14:42:20 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1663068

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that new disease-modifying treatments for dementia will be available on the NHS.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	200922
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>To be made routinely available to National Health Service patients in England, new medicines must receive a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) and a positive recommendation from the National Institute for Health and Care Excellence (NICE) to demonstrate clinical and cost effectiveness.</p><p>A number of potential new disease modifying treatments for Alzheimer’s disease are in development and MHRA, NICE, NHS England and the Department are working closely to ensure that arrangements are in place to support the adoption of any new licensed and NICE recommended treatment for Alzheimer’s disease as soon as possible.</p><p>NICE’s appraisal of lecanemab for treating early Alzheimer's disease is currently underway and, subject to licensing and the company engaging in the process, NICE expects to publish final guidance in July 2024 as close to licence as possible. NICE is also due to begin its appraisal of donanemab for treating early Alzheimer’s disease later this year.</p><p>To prepare for these appraisals, and the expected pipeline of further disease modifying dementia treatments, the NICE Health Technology Assessment Innovation Laboratory has already started working on identifying potential challenges that might face the evaluation of these medicines and ways of addressing them.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 14:38:04 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1658209

	registered interest
	date	05/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Leukaemia: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to support people who have been diagnosed with leukaemia.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	197734
	answer	answer is ministerial correction date of answer 11/09/2023 answer text <p>The Department has taken steps to ensure that the National Health Service prioritises cancer treatment, including leukaemia. The NHS Long Term Plan states that, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support. This includes provision of end of treatment summaries, empowering people to manage their care and the impact of their cancer. To support delivery of our cancer care priorities, including expanding treatment capacity across NHS hospital trusts, NHS England is providing over £390 million in cancer service development funding to Cancer Alliances.</p><p>More treatment is happening, with over 335,000 people receiving their first cancer treatment in the 12 months leading up to June 2023, representing an increase of more than 22,000 on the same period pre-pandemic. More information on cancer waiting times is available at the following link:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/</a></p><p>We are committed to ensuring that all cancer patients get access to interventions, ensuring care is focused on what matters most to each person.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/09/2023 16:43:15 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1658220

	registered interest
	date	05/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that children with suspected allergies receive a diagnosis.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	197741
	answer	answer is ministerial correction date of answer 11/09/2023 answer text <p>To support healthcare professionals in ensuring that children with suspected allergies receive a diagnosis, the National Institute for Health and Care Excellence (NICE) has published a range of evidence-based best practice guidance for clinicians and commissioners. These include guidance on the diagnosis and treatment of drug and food allergy in under-19s [CG116]; the diagnosis and management of atopic eczema in the under-12s [CG57]; and diagnosing, monitoring, and managing asthma in adults, young people and children [NG80].</p><p>NICE guidelines represent best practice, and health professionals, including general practitioners, are expected to take them fully into account. It should be noted, however, that the guidelines are not mandatory and do not replace the judgement of clinicians in determining the most appropriate treatment for individual patients.</p> answering member constituency Colchester answering member printed Will Quince question first answered 11/09/2023 16:39:12 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy

1655901

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Strokes: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve access to treatment for people who have had a stroke.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	195988
	answer	answer is ministerial correction date of answer 08/09/2023 answer text <p>The National Stroke Service Model, published by NHS England in May 2021, articulates optimal evidenced-based stroke care. Patients are expected to be seen by a stroke specialist clinician within 60 minutes of arrival and have their treatment plan determined.</p><p>From 1 April 2021, 20 Integrated Stroke Delivery Networks (ISDNs) were established giving full coverage across England. ISDNs include all key stakeholders across the system including providers, commissioners, clinicians and patient representative across the whole stroke pathway.</p><p>ISDNs are responsible for delivering optimal stroke pathways, based on best evidence, which ensures that more people who experience a stroke receive high-quality specialist care, from pre-hospital, through to rehabilitation and life after stroke.</p> answering member constituency Colchester answering member printed Will Quince question first answered 08/09/2023 12:06:17 answering member 4423 label Biography information for Will Quince
	tabling member	4079 label Biography information for Julian Sturdy